- Home
- BNR vs CCM Comparison
BNR vs CCM Comparison
Compare BNR & CCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNR
- CCM
- Stock Information
- Founded
- BNR 2014
- CCM 1997
- Country
- BNR China
- CCM China
- Employees
- BNR N/A
- CCM N/A
- Industry
- BNR Medical Specialities
- CCM Medical/Nursing Services
- Sector
- BNR Health Care
- CCM Health Care
- Exchange
- BNR Nasdaq
- CCM Nasdaq
- Market Cap
- BNR 29.1M
- CCM 33.3M
- IPO Year
- BNR 2020
- CCM 2009
- Fundamental
- Price
- BNR $3.70
- CCM $5.66
- Analyst Decision
- BNR
- CCM
- Analyst Count
- BNR 0
- CCM 0
- Target Price
- BNR N/A
- CCM N/A
- AVG Volume (30 Days)
- BNR 36.5K
- CCM 2.5K
- Earning Date
- BNR 08-21-2025
- CCM 04-25-2025
- Dividend Yield
- BNR N/A
- CCM N/A
- EPS Growth
- BNR N/A
- CCM N/A
- EPS
- BNR N/A
- CCM N/A
- Revenue
- BNR $72,112,038.00
- CCM $52,603,198.00
- Revenue This Year
- BNR $136.32
- CCM N/A
- Revenue Next Year
- BNR N/A
- CCM N/A
- P/E Ratio
- BNR N/A
- CCM N/A
- Revenue Growth
- BNR 0.53
- CCM N/A
- 52 Week Low
- BNR $2.18
- CCM $3.80
- 52 Week High
- BNR $7.90
- CCM $10.90
- Technical
- Relative Strength Index (RSI)
- BNR 59.32
- CCM 40.37
- Support Level
- BNR $3.06
- CCM $5.57
- Resistance Level
- BNR $3.50
- CCM $5.95
- Average True Range (ATR)
- BNR 0.25
- CCM 0.23
- MACD
- BNR 0.01
- CCM 0.00
- Stochastic Oscillator
- BNR 69.57
- CCM 48.19
About BNR Burning Rock Biotech Limited
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through our in-hospital model and smaller hospitals through our central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.
About CCM Concord Medical Services Holdings Limited
Concord Medical Services Holdings Ltd operates radiotherapy and diagnostic imaging centers in China. The company is involved in the leasing of radiotherapy and diagnostic imaging equipment, provision of management services to hospitals, medicine sales, and provision of premium cancer and proton treatment services. The company has two operating segments, including network and hospital. Its network includes radiotherapy centers, diagnostic imaging centers, and centers providing other treatment and diagnostic services.